# Vasopressin Effects on Human Social Communication

> **NCT01327027** · PHASE1 · COMPLETED · sponsor: **Bowdoin College** · enrollment: 225 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Vasopressin, Arginine, ADH
- **DRUG:** Placebo; Sterile Saline

## Key facts

- **NCT ID:** NCT01327027
- **Lead sponsor:** Bowdoin College
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2015-12
- **Final completion:** 2017-04
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327027, "Vasopressin Effects on Human Social Communication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01327027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*